The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study
Open accessAbstract
Background—: The optimal duration of dual antiplatelet therapy (DAPT) after implantation of drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month DAPT would be noninferior to 12-month DAPT after implantation of drug-eluting stents. Methods and Results—: We randomly assigned 1443 patients undergoing implantation of drug-eluting stents to receive 6- or 12-month DAPT (in a 1:1 ratio). The primary end point was a target vessel failure, defined as the composite of cardiac death, myocardial infarction, or ischemia-driven target vessel revascularization at 12 months. Rates of target vessel failure at 12 months were 4.8% in the 6-month DAPT group and 4.3% in the 12-month DAPT group (the upper limit of 1-sided 95% confidence interval, 2.4%; P =0.001 for noninferiority with a predefined noninferiority margin of 4.0%). Although stent thrombosis tended to occur more frequently in the 6-month DAPT group than in the 12-month group (0.9% versus 0.1%; hazard ratio, 6.02; 95% confidence interval, 0.72–49.96; P =0.10), the risk of death or myocardial infarction did not differ in the 2 groups (2.4% versus 1.9%; hazard ratio, 1.21; 95% confidence interval, 0.60–2.47; P =0.58). In the prespecified subgroup analysis, target vessel failure occurred more frequently in the 6-month DAPT group than in the 12-month group (hazard ratio, 3.16; 95% confidence interval, 1.42–7.03; P =0.005) among diabetic patients. Conclusions—: Six-month DAPT did not increase the risk of target vessel failure at 12 months after implantation of drug-eluting stents compared with 12-month DAPT. However, the noninferiority margin was wide, and the study was underpowered for death or myocardial infarction. Our results need to be confirmed in larger trials. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00698607.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Iakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.015 · Cited by 1,911
Daemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Jüni, P., Sianos, G., Hellige, G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60314-6 · Cited by 1,757
Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192663 · Cited by 1,700
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Finn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Analysis of survival by tumor response.
Anderson, J. R., Cain, K. C., & Gelber, R. D. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.11.710 · Cited by 1,107
King, S. B., Smith, S. C., Hirshfeld, J. W., Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.188208 · Cited by 1,014
Analysis of survival by tumor response.
Anderson, J. R., & Davis, R. B. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.1.115 · Cited by 1,000
Fox, K., Poole-Wilson, P., Henderson, R., Clayton, T., Chamberlain, D., Shaw, T., Wheatley, D., & Pocock, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09894-x · Cited by 901
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
Eisenstein, E. L., Anstrom, K. J., Kong, D. F., Shaw, L. K., Tuttle, R. H., Mark, D. B., Kramer, J. M., Harrington, R. A., Matchar, D. B., Kandzari, D. E., et al. (2007) · JAMA · doi:10.1001/jama.297.2.joc60179 · Cited by 870
Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization
Windecker, S., Remondino, A., Eberli, F. R., Jüni, P., Räber, L., Wenaweser, P., Togni, M., Billinger, M., Tüller, D., Seiler, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051175 · Cited by 593
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Park, S.-J., Park, D.-W., Kim, Y.-H., Kang, S.-J., Lee, S.-W., Lee, C. W., Han, K.-H., Park, S.-W., Yun, S.-C., Lee, S.-G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001266 · Cited by 511
Self-citationBovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-4-256 · Cited by 479
Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans
Farb, A., Burke, A. P., Kolodgie, F. D., & Virmani, R. (2003) · Circulation · doi:10.1161/01.cir.0000091115.05480.b0 · Cited by 478
Fajadet, J., Wijns, W., Laarman, G.-J., Kuck, K.-H., Ormiston, J., Münzel, T., Popma, J. J., Fitzgerald, P. J., Bonan, R., & Kuntz, R. E. (2006) · Circulation · doi:10.1161/circulationaha.105.591206 · Cited by 464
Morice, M.-C., Colombo, A., Meier, B., Serruys, P., Tamburino, C., Guagliumi, G., Sousa, E., Stoll, H.-P., & REALITY Trial Investigators, F. T. (2006) · JAMA · doi:10.1001/jama.295.8.895 · Cited by 458
Airoldi, F., Colombo, A., Morici, N., Latib, A., Cosgrave, J., Buellesfeld, L., Bonizzoni, E., Carlino, M., Gerckens, U., Godino, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.686048 · Cited by 455
Hallas, J., Dall, M., Andries, A., Andersen, B. S., Aalykke, C., Hansen, J. M., Andersen, M., & Lassen, A. T. (2006) · BMJ · doi:10.1136/bmj.38947.697558.ae · Cited by 403
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Kimura, T., Morimoto, T., Nakagawa, Y., Tamura, T., Kadota, K., Yasumoto, H., Nishikawa, H., Hiasa, Y., Muramatsu, T., Meguro, T., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808311 · Cited by 358
The Effect of Aspirin Dosing on Platelet Function in Diabetic and Nondiabetic Patients
DiChiara, J., Bliden, K. P., Tantry, U. S., Hamed, M. S., Antonino, M. J., Suarez, T. A., Bailon, O., Singla, A., & Gurbel, P. A. (2007) · Diabetes · doi:10.2337/db07-0707 · Cited by 229
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jiménez‐Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.106 · Cited by 113
Brar, S. S., Kim, J., Brar, S. K., Zadegan, R., Ree, M. H., Liu, I.-L. A., Mansukhani, P. W., Aharonian, V. J., Hyett, R., & Shen, A. Y. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.063 · Cited by 112
DiChiara, J., Bliden, K. P., Tantry, U. S., Chaganti, S. K., Kreutz, R. P., Gesheff, T. B., Geshefe, T. A., Kreutz, Y., & Gurbel, P. A. (2007) · Platelets · doi:10.1080/09537100701206824 · Cited by 55
Hahn, J., Song, Y. B., Choi, J., Choi, S., Lee, S. Y., Park, H. S., Hur, S., Lee, S., Han, K., Rha, S., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0347 · Cited by 26
Self-citation
Cited by
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Metadata
- Authors
- Gwon, H.-C., Hahn, J.-Y., Park, K. W., Song, Y. B., Chae, I.-H., Lim, D.-S., Han, K.-R., Choi, J.-H., Choi, S.-H., Kang, H.-J., Koo, B.-K., Ahn, T., Yoon, J.-H., Jeong, M.-H., Hong, T.-J., Chung, W.-Y., Choi, Y.-J., Hur, S.-H., Kwon, H.-M., Jeon, D.-W., Kim, B.-O., Park, S.-H., Lee, N.-H., Jeon, H.-K., Jang, Y., & Kim, H.-S.
- Venue
- Circulation
- Published
- 2012-01-24
- Volume
- 125
- Issue
- 3
- Pages
- 505-513
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2081613030
- Cited by
- 614
- References
- 29
- FWCI
- 27.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.